Who is this course for?
Clinicians, therapists, and mental health professionals interested in psychedelic-assisted therapy, cancer-related existential distress, and integration work.
This course covers psilocybin-assisted therapy for existential distress in cancer patients, including the study rationale, participant selection, preparation, dosing-session support, and integration. It also discusses the historical and cultural context of psychedelics and the role of the therapist in supporting inner-
IPI
English
000 years
This course examines psilocybin-assisted therapy for existential distress in cancer patients. It explains how the study was shaped by the concept of existential distress, including how participants were selected, how preparation was structured, and how integration was approached after the dosing session. The content also reviews the broader history of psychedelics in culture, including their long-standing use in indigenous and religious contexts. It presents existential distress as a response to cancer diagnosis marked by fear, sadness, loss of meaning, and questioning of life’s purpose. The course describes the therapist’s role as supportive and minimally directive during the session, with emphasis on helping participants remain with their inner experience. It also addresses post-session integration and the relevance of transpersonal psychology in spiritual and existential work.
Clinicians, therapists, and mental health professionals interested in psychedelic-assisted therapy, cancer-related existential distress, and integration work.
Educational platform co-founded by Dr. Will Van Derveer and Keith Kurlander that trains therapists, physicians, and nurses in psychedelic-assisted therapy through a year-long online program taught by 50+ experts including Robin Carhart-Harris, Michael Pollan, and Rick Doblin. IPI's curriculum covers evidence-based protocols for PTSD, depression, and anxiety, and partners with the Usona Institute and MAPS to prepare clinicians for emerging MDMA- and psilocybin-assisted treatments.
Clinicians, therapists, and mental health professionals interested in psychedelic-assisted therapy, cancer-related existential distress, and integration work.
Time commitment: 000 years.
This listing does not have a public price yet. Check [object Object] for current tuition, fees, or application-based pricing.
The current listing status is Discontinued. Use the provider website for the latest enrollment status.
By Clerkenwell Health
Shares course skills and categories
Psilocybin therapy courses covering clinical and educational material on psilocybin-assisted psychotherapy, preparation, dosing, and integration. Listings on the page vary by provider and format.
Next cohort: May 20, 2026
By Alma Institute
Shares course skills and categories
Psychedelic-assisted psychotherapy courses covering clinical training, integration, and related therapeutic skills. Listings on this page vary by provider, format, and audience.
Next cohort: May 20, 2026
By Alma Institute
Shares course skills and categories
Psychotherapy skill topic focused on courses related to psychedelic therapy, integration, facilitation, ethics, and trauma-informed care. It is used to group courses that cover psychotherapy-adjacent practice and clinical topics.
Next cohort: Jul 13, 2026